NaviHealth BioTech rose over 240% during the session and had previously announced plans for the acquisition of all shares of Conflux.

According to Mars Finance, Hong Kong-listed company Navigating Pharmaceuticals Biotech (00399) saw higher trade volumes and rose nearly 240% during the morning session, with the stock price reaching a high of 0.7 HKD before falling back to around 0.34 HKD. Previously, the company announced plans for the acquisition of all equity in the Blockchain project Conflux to expand its presence in the Blockchain field, and two founding members of Conflux currently serve as its executive directors.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)